mRNA vaccine technology is at the forefront of making this possible.

If we can develop the technology and APIs to manufacture PrEP locally, with other mRNA-based products, SA could position itself at the forefront of this initiative. The world-renowned Afrigen Biologics mRNA hub in Cape Town already aims to contribute to this project by working on the development of new vaccines for diseases that are rampant in lower and middle-income countries.